Cluster: Archive

Growing threat to plant and animal life

This content was published on May 22, 2003 The number of plants and animals on the Red List of Threatened Species has risen in the last ten years. Meanwhile, more and more land is being swallowed up for development. “If you compare the situation in Switzerland with other countries in Europe, there is a higher percentage of species on the Red List,” said…

Swiss boost for European space programme

This content was published on May 21, 2003 The government announced on Wednesday that it would raise its contribution to the agency to SFr133 million ($103 million) by 2006. The announcement comes ahead of an ESA conference due to take place next week in Paris, where Switzerland is expected to reaffirm its commitment to space research. A key aim of the meeting is…

Central bank downplays sliding dollar

This content was published on May 21, 2003 The franc has risen to its highest level in seven years against the dollar, increasing the pressure on Switzerland’s export-dependent economy. “The Swiss National Bank has demonstrated several times in recent months that it does not hesitate to take decisive policy measures in such a case,” said Ulrich Kohli, the bank’s chief economist. “It is…

Anti-tobacco convention adopted in Geneva

This content was published on May 21, 2003 It was concluded during a session of the World Health Assembly, the decision-making body of the World Health Organization (WHO), which is also focusing on the fight against the Sars pneumonia virus. The Framework Convention on Tobacco Control aims to curb cancer and chronic heart disease by limiting the advertising, promotion, sale and smuggling of…

Centerpulse considers US counter-offer

This content was published on May 21, 2003 On Wednesday the Zurich-based company confirmed it was considering an offer from Zimmer worth around SFr4.26 billion ($3.3 billion). Zimmer’s bid includes a cash offer of SFr120 per Centerpulse share, plus 3.68 Zimmer shares for every Centerpulse share. The deal values Centerpulse at around SFr350 per share. Zimmer’s bid has outstripped an offer made in…

Dollar tumbles to seven-year low against franc

This content was published on May 20, 2003 Experts say the prices of Swiss goods on the global market are likely to drop in the near future as a direct result. The United States currency has also lost nearly 40 per cent of its value against the euro in the past two years. A prolonged fall in the value of the dollar could…

The steely hand that built a Swiss chip star

This content was published on May 20, 2003 The Swiss electrical engineer and his co-founder took the firm from null to SFr125 million in eight years. Stahl did nothing by the book because the book had not been written yet. He acquired companies many times the size of his own, not once but twice. Further, he relied too much on one customer, went…

Tumbling dollar bodes ill for Swiss exporters

This content was published on May 20, 2003 The slumping US currency threatens to further damage Switzerland’s already weak export sector, just as it is showing tentative signs of recovery. The dollar remained below SFr1.30 on Tuesday, following comments at the weekend by US Treasury Secretary, John Snow. His remarks, at a meeting of G-8 finance officials in France, appeared to suggest that…

Swiss visit reveals reality of life in North Korea

This content was published on May 20, 2003 Her tour of the communist country included stops in villages outside the capital, Pyongyang, to see how and where Swiss aid is targeted. The Swiss Agency for Development and Cooperation (SDC) began humanitarian operations inside North Korea in 1995, when it responded to a severe drought and famine by providing emergency food aid. A permanent…

Roche collaborates on new malaria drug

This content was published on May 20, 2003 The novel partnership with New Delhi-based Ranbaxy Laboratories should ensure the rapid development of the synthetic drug. Geneva-based Medicines for Malaria Venture (MMV) helped secure the unconventional partnership which could serve as a model for fighting diseases in developing countries. “Ranbaxy will ensure cost-effective further development and delivery of this potential new anti-malaria medicine,” René…

Cluster: Archive

Popular Stories

Most Discussed

Cluster: Archive

More

Growing threat to plant and animal life

More

Swiss boost for European space programme

More

Central bank downplays sliding dollar

More

Anti-tobacco convention adopted in Geneva

More

Centerpulse considers US counter-offer

More

Dollar tumbles to seven-year low against franc

More

The steely hand that built a Swiss chip star

More

Tumbling dollar bodes ill for Swiss exporters

More

Swiss visit reveals reality of life in North Korea

More

Roche collaborates on new malaria drug

Popular Stories

Most Discussed